Interleukin-12 and Interleukin-6 Gene Polymorphisms and Risk of Bladder Cancer in the Iranian Population |
Ebadi, Nader
(Department of Medical Genetics, School of Medicine Tehran University of Medical Sciences)
Jahed, Marzieh (Varamin) Mivehchi, Mohamad (Young Researchers' Club, Varamin - Pishva Branch, Islamic Azad University) Majidizadeh, Tayebeh (Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology) Asgary, Mojgan (Department of Pathology-Hasheminejad Clinical Research Developing Center, School of Medicine Tehran University of Medical Sciences) Hosseini, Seyed Ali (Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology) |
1 | Arnson Y, Shoenfeld Y, Amital H (2010). Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun, 34, 258-65. DOI ScienceOn |
2 | Belluco C, Olivieri F, Bonafe M, et al (2003). -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res, 9, 2173-6. |
3 | Bergholdt R, Ghandil P, Johannesen J, et al (2004). Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet, 41, 39. DOI |
4 | Chen H, Cheng S, Wang J, et al (2012). Interleukin-12B rs3212227 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep, 39, 10235-42. DOI ScienceOn |
5 | Chen MF, Lin PY, Wu CF, et al (2013). IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One, 8, 61901. DOI |
6 | Colombo MP, Trinchieri G (2002). Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev, 13, 155-68. DOI ScienceOn |
7 | Enewold L, Mechanic LE, Bowman ED, et al (2009). Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev, 18, 215-22. DOI ScienceOn |
8 | George DJ, Halabi S, Shepard TF, et al (2005). The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480. Clin Cancer Res, 11, 1815-20. DOI ScienceOn |
9 | Iliopoulos D, Jaeger SA, Hirsch HA, et al (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell, 39, 493-506. DOI ScienceOn |
10 | Grivennikov S, Karin M (2008). Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell, 13, 7-9. DOI ScienceOn |
11 | Hagiwara E, Takahashi KI, Okubo T, et al (2001). Cigarette smoking depletes cells spontaneously secreting Th(1) cytokines in the human airway. Cytokine, 14, 121-6. DOI ScienceOn |
12 | Iliopoulos D, Hirsch HA, Struhl K (2009). An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell, 139, 693-706. DOI ScienceOn |
13 | Jaiswal PK, Singh V, Srivastava P, et al (2013). Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population. Gene, 519, 128-34. DOI ScienceOn |
14 | Kishimoto T (2005). Interleukin-6: from basic science to medicine--40 years in immunology. Annu Rev Immunol, 23, 1-21. DOI ScienceOn |
15 | Kobeissi LH, Yassine IA, Jabbour ME, et al (2013). Urinary bladder cancer risk factors: a Lebanese case- control study. Asian Pac J Cancer Prev, 14, 3205-11. 과학기술학회마을 DOI ScienceOn |
16 | Lagmay JP, London WB, Gross TG, et al (2009). Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor). Clin Cancer Res, 15, 5234-9. DOI ScienceOn |
17 | Letasiova S, Medve'ova A, Sovcikova A, et al (2012). Bladder cancer, a review of the environmental risk factors. Environ Health, 11, 11. DOI ScienceOn |
18 | Morgan L, Cooper J, Montgomery H, et al (2006). The interleukin-6 gene -174G>C and -572G>C pro- moter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry, 77, 915-7. DOI ScienceOn |
19 | Liu RY, Song X, Chen P, et al (2012). Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals. Exp Ther Med, 3, 655-64. |
20 | Lin CY, Chien JW (2004). Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome. Acta Paediatr Taiwan, 45, 77-80. |
21 | Machado JC, Figueiredo C, Canedo P, et al (2003). A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology, 125, 364-71. DOI ScienceOn |
22 | Murakami S, Okubo K, Tsuji Y, et al (2004). Serum interleukin-12 levels in patients with gastric cancer. Surg Today, 34, 1014-9. DOI |
23 | Noguchi Y, Jungbluth A, Richards EC, et al (1996). Effect of interleukin 12 on tumor induction by 3-methylcholanthrene. Proc Natl Acad Sci U S A, 93, 11798-801. DOI |
24 | Otunctemur A, Koklu I, Ozbek E, et al (2014). Are Bladder Neoplasms More Aggresive in Patients with a Smokingrelated Second Malignancy? Asian Pac J Cancer Prev, 15, 4025-8. DOI ScienceOn |
25 | Qin Q, Xu X, Wang X, et al (2013). Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev, 14, 3117-21. 과학기술학회마을 DOI ScienceOn |
26 | Smyth MJ, Dunn GP, Schreiber RD (2006). Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol, 90, 1-50. DOI ScienceOn |
27 | Rakoff-Nahoum S (2006). Why cancer and inflammation? Yale J Biol Med, 79, 123-30. |
28 | Sangro B, Melero I, Qian C, et al (2005). Gene therapy of cancer based on interleukin 12. Curr Gene Ther, 5, 573-81. DOI |
29 | Schafer ZT, Brugge JS (2007). IL-6 involvement in epithelial cancers. J Clin Invest, 117, 3660-3. DOI ScienceOn |
30 | Šery O, Hladilová R, Novotny M, et al (2003). Association between -174 G/C polymorphism of interleukin-6 gene and alcoholism. Acta Neuropsychiatrica, 15, 257-61. DOI ScienceOn |
31 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
32 | Tan D, Wu X, Hou M, et al (2005). Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol, 174, 753-6. DOI ScienceOn |
33 | Sopori M (2002). Effects of cigarette smoke on the immune system. Nat Rev Immunol, 2, 372-7. DOI ScienceOn |
34 | Tahara E (1990). Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol, 116, 121-31. DOI |
35 | Tamandani DM, Shekari M, Suri V (2009). Interleukin-12 gene polymorphism and cervical cancer risk. Am J Clin Oncol, 32, 524-8. DOI ScienceOn |
36 | Terry CF, Loukaci V, Green FR (2000). Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem, 275, 18138-44. DOI ScienceOn |
37 | Waldner MJ, Foersch S, Neurath MF (2012). Interleukin-6--a key regulator of colorectal cancer development. Int J Biol Sci, 8, 1248-53. DOI |
38 | Wolf SF, Temple PA, Kobayashi M, et al (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 146, 3074-81. |
39 | Zhang H, Xu Y, Li L, et al (2012). The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis. Urol Int, 88, 447-53. DOI ScienceOn |
40 | Xu B, Niu XB, Wang ZD, et al (2011). IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Biol Rep, 38, 2589-96. DOI |
41 | Yang XQ, Xu C, Sun Y, et al (2013). Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 14, 2583-9. 과학기술학회마을 DOI ScienceOn |
42 | Zhu Z, Shen Z, Xu C (2012). Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer. Mediators Inflamm, 2012, 528690. |
43 | Yu Y, Wang W, Zhai S, et al (2012). IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review. Mol Biol Rep, 39, 8457-63. DOI ScienceOn |
44 | Zhang T, Wang H (2013). Variants of interleukin-16 associated with gastric cancer risk. Asian Pac J Cancer Prev, 14, 5269-73. 과학기술학회마을 DOI ScienceOn |
45 | Zhou L, Yao F, Luan H, et al (2012). Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-control studies. Gene, 510, 71-7. DOI ScienceOn |
46 | Smith AJ, D'Aiuto F, Palmen J, et al (2008). Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism. Clin Chem, 54, 841-50. DOI ScienceOn |
47 | Iranian Ministry of Health and Medical Education HD, Department of Prevention of Non Contagious Diseases (2012). Iranian annual of national cancer registration report 2009/2010, (In Persian). |
48 | Bozcuk H, Uslu G, Samur M, et al (2004). Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine, 27, 58-65. DOI ScienceOn |
![]() |